Follow the Alembic Pharmaceuticals Limited share price and the full management transaction log of the company, a listed issuer based in India. Shares trade on the IN market, under the oversight of SEBI (PIT + SAST). Operating in the Health Care sector, Alembic Pharmaceuticals Limited has logged 34 public disclosures. Market capitalisation: €156.7bn. The latest transaction was reported on 30 September 2025 (Purchase). Among the most active insiders: Chirayu Ramanbhai Amin HUF. Every trade is accessible without an account.
34
Insider Decl.
n/a
Thresholds
€5m
32 ops.
Buy Volume
n/a
2 ops.
Sell Volume
Analyst consensus: bullish or bearish?
Analysts rate Alembic Pharmaceuticals Limited Buy (bullish), based on 10 analysts. Average price target: ₹918.20.
18Σ signal
Buys €5mn/a Sells
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Fundamental score
Ranked 9,883 of 29,062 companies
59.5
score / 100
Value
48
Quality
71
FCF yld1.8%
Earn yld4.3%
EV/EBITDA15.5x
ROE12%
Gross mgn67%
Net mgn9.4%
Debt/EBITDA1.3x
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Σ
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
Alembic Pharmaceuticals Limited is an India-based pharmaceutical company that specializes in the manufacturing of generic drugs and pharmaceutical products. It is listed on the Bombay Stock Exchange.